Presenters
Clinical Reader in Diabetes and Cardiovascular Disease
Prof. Janaka Karalliedde, MBBS, FRCP, FHEA, PhD
Course Details
The aim of this webinar is to provide updates on how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it helps make the management of a complex disease more simple.
Estimated time of Completion: 45 mins
CPD Points: 0.75 Point
PRC Program No: PROG-2022-47761
Offering Simplicity, Safety and Success in the Management of T2D Course Outline
- SIMPLICITY: Simplifying type 2 diabetes management: When to choose Linagliptin and Why
- SAFETY: Safety Cardiovascular and Renal (CARMELINA and CAROLINA): An Extensive Dataset from a Unique CVOT Program
- SUCCESS: Linagliptin – a successful choice and treatment option in a broad range of patients with type 2 diabetes
- Course Evaluation
PC-PH-104299 / October 2022